As the fraud trial of Theranos founder Elizabeth Holmes headlines the pharma legal news, other court-related cases are taking place, including a ruling in the legal spat between Takeda and AbbVie over a supply agreement for the prostate cancer drug Lupron.

After a year-long delay due to Covid-19, Theranos founder and CEO Elizabeth Holmes headed to court on Sept. 8 to face multiple criminal fraud charges that could land the former billionaire in prison for more than a decade.

Elizabeth Holmes is set to go to trial in March 2021 after a last-ditch effort to throw out the pending criminal charges against her failed

A federal judge dismissed some of the criminal charges Elizabeth Holmes is facing.

Theranos founder Elizabeth Holmes and her former second-in-command at the Silicon Valley blood-testing startup were ordered to stand trial in 2020 on fraud charges stemming from their claims about the company’s technology, court documents show.

Elizabeth Holmes, the founder of the now-failed Theranos, is a subject of fascination for many people.

Here is a look at BioSpace’s top 10 stories of 2018.

Theranos Inc. – the once-celebrated Silicon Valley blood-testing firm – will dissolve itself months after top executives were indicted for defrauding investors, the Wall Street Journal reported.

Theranos Inc. founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they engaged in schemes to defraud investors, doctors and patients, the U.S. Justice Department announced.

The Wall Street Journal reported that Theranos Inc. secured a loan from Fortress Investment Group.